Allarity Therapeutics Inc
ALLR
Get informed when a big investor buys or sells
+ FollowMarket Cap$19.25M
Close$
$1.15
11.9% downside
Current Fair Value
11.9% downsideOvervalued by 11.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $19.25 Million |
|---|---|
| Enterprise Value | $-479,024.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.78 |
| Beta | 0.53 |
| Outstanding Shares | 15,968,591 |
Return
| Return on Equity | -0.26% |
|---|---|
| Return on Assets | -0.05% |
| Return on Invested Capital | -153.76% |
Valuation & Multiples
| P/E Ratio | -1.68 |
|---|---|
| PEG | -255.07 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -1.39 |
| Enterprise Value to EBIT | 0.05 |
| Enterprise Value to Net Income | 26 |
| Total Debt to Enterprise | -0.17 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-0.22
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 21, 2026
EPS Estimate
$-0.25
Average shareholder expectationRevenue Estimate
$25,000
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data